BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2568982)

  • 1. L-asparaginase for treatment of lymphoid neoplasia in dogs.
    Rogers KS
    J Am Vet Med Assoc; 1989 Jun; 194(11):1626-30. PubMed ID: 2568982
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic combination chemotherapy of canine lymphosarcoma.
    MacEwen EG; Brown NO; Patnaik AK; Hayes AA; Passe S
    J Am Vet Med Assoc; 1981 Jun; 178(11):1178-81. PubMed ID: 6895078
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
    Horikoshi A; Takei K; Iriyama N; Uenogawa K; Ishizuka H; Shiraiwa H; Hosokawa Y; Sawada S; Kitoh T
    Acta Haematol; 2009; 122(1):54-7. PubMed ID: 19816010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; van Heerde P; Misdorp W
    Eur J Cancer; 1990; 26(8):891-5. PubMed ID: 2145933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia.
    Weller RE; Theilen GH; Madewell BR
    J Am Vet Med Assoc; 1982 Nov; 181(9):891-3. PubMed ID: 6897239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asparaginase-associated pancreatitis in a dog.
    Schleis SE; Rizzo SA; Phillips JC; LeBlanc AK
    Can Vet J; 2011 Sep; 52(9):1009-12. PubMed ID: 22379203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-asparaginase in the treatment of neoplastic diseases of the dog, cat and cow.
    Hardy WD; Old LJ
    Recent Results Cancer Res; 1970; 33():131-9. PubMed ID: 5005093
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia.
    Speas AL; Lyles SE; Wirth KA; Fahey CE; Kow K; Lejeune AT; Milner RJ
    J Vet Emerg Crit Care (San Antonio); 2018 Mar; 28(2):130-139. PubMed ID: 29469204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single-dose L-asparaginase on coagulation values in healthy dogs and dogs with lymphoma.
    Rogers KS; Barton CL; Benson PA; Green RA
    Am J Vet Res; 1992 Apr; 53(4):580-4. PubMed ID: 1586032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma.
    MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD
    J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bovine lymphosarcoma with L-asparaginase.
    Masterson MA; Hull BL; Vollmer LA
    J Am Vet Med Assoc; 1988 May; 192(9):1301-2. PubMed ID: 3391857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of a dog with malignant lymphoma.
    Walsh MB; Brown SR
    Vet Med Small Anim Clin; 1981 Apr; 76(4):511-2. PubMed ID: 6908768
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and adverse events of continuous l-asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.
    Nakagawa T; Kojima M; Ohno K; Chambers JK; Uchida K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Tsujimoto H
    Vet Comp Oncol; 2022 Mar; 20(1):102-108. PubMed ID: 34213084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of reticulum cell sarcoma treated with L-asparaginase and antibody to L-asparaginase].
    Ueda E; Yagura T; Tsubura E; Yamamura Y
    Gan No Rinsho; 1970 Nov; 16(11):1122-7. PubMed ID: 4922050
    [No Abstract]   [Full Text] [Related]  

  • 17. Uric acid and phosphorus excretion in dogs with lymphosarcoma.
    Page RL; Leifer CE; Matus RE
    Am J Vet Res; 1986 Apr; 47(4):910-2. PubMed ID: 3754406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy.
    Calvert CA; Leifer CE
    J Am Vet Med Assoc; 1981 Nov; 179(10):1011-2. PubMed ID: 6896200
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-morphological analysis of chemotherapy effectiveness in spontaneous hemoblastoses in dogs].
    Iliukhin AV; Ponomar'kov VI; Kliuchanskaia NV
    Vopr Onkol; 1985; 31(3):88-91. PubMed ID: 3857785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.